Dr. Karyn Frick was puzzled. Her two-year study, begun with funding from Women's Health Research at Yale in 2005, found that long-term treatment with the sex hormones estrogen and progesterone did not improve memory as anticipated.
Mar 2, 2018
0
3
Two University of Houston researchers, working to find cancer cures, received grants from the Cancer Prevention & Research Institute of Texas (CPRIT), the organization that funds groundbreaking cancer research and prevention ...
Mar 1, 2018
0
26
An international group of clinicians and scientists representing the Clinical Pharmacogenetics Implementation Consortium (CPIC) published the first-ever clinical practice guideline for using CYP2D6 genotype to guide tamoxifen ...
Feb 1, 2018
0
7
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential ...
Jan 9, 2018
0
45
Estrogens are powerful hormones important for the formation and function of the nervous, reproductive and cardiovascular systems.
Dec 5, 2017
0
1
An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta (ERĪ²), according to new research published on the cover of Oncotarget. The findings ...
Nov 15, 2017
0
11
Dr. Jung-Mo Ahn, associate professor of chemistry and biochemistry at The University of Texas at Dallas, has designed a small molecule that could help breast cancer patients for whom current treatments no longer work.
Nov 9, 2017
0
3
The reward center of the brain is much more attuned to the pleasurable effects of alcohol when estrogen levels are elevated, an effect that may underlie the development of addiction in women, according to a study on mice ...
Nov 6, 2017
0
48
A University of Arizona Cancer Center research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.
Oct 30, 2017
0
31
Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks. The new agent ...
Aug 30, 2017
0
5
